Veritas In Silico Inc. (TYO:130A)
Japan flag Japan · Delayed Price · Currency is JPY
644.00
+3.00 (0.47%)
Last updated: Jul 25, 2025

Theseus Pharmaceuticals Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,113173.361,5491,4841,689
Short-Term Investments
-2,000---
Cash & Short-Term Investments
2,1132,1731,5491,4841,689
Cash Growth
25.10%40.30%4.36%-12.10%-
Receivables
18.2821.0259.0735.784.33
Inventory
12.213.3516.3216.0316.81
Prepaid Expenses
2.151.661.651.771.07
Other Current Assets
25.1322.683.069.1617.98
Total Current Assets
2,1702,2321,6291,5471,729
Property, Plant & Equipment
11.3614.1223.6547.6820.38
Other Intangible Assets
11.081.412.294.63
Other Long-Term Assets
1.641.691.271.420.82
Total Assets
2,1842,2491,6561,5991,755
Accounts Payable
27.2433.6624.4624.1829.4
Current Income Taxes Payable
0.712.852.852.8514.31
Current Unearned Revenue
--26.1424.4224.42
Other Current Liabilities
26.872.926.444.542.69
Total Current Liabilities
54.8239.4179.8955.9970.82
Other Long-Term Liabilities
0---0
Total Liabilities
54.8239.4179.8955.9970.82
Common Stock
77.1877.189090790
Additional Paid-In Capital
2,3362,3361,4531,5941,424
Retained Earnings
-283.37-203.3933.05-141.38-530.23
Comprehensive Income & Other
-0-0--0
Shareholders' Equity
2,1302,2101,5761,5431,684
Total Liabilities & Equity
2,1842,2491,6561,5991,755
Net Cash (Debt)
2,1132,1731,5491,4841,689
Net Cash Growth
25.10%40.30%4.36%-12.10%-
Net Cash Per Share
325.65341.13281.59269.83377.41
Filing Date Shares Outstanding
6.496.495.52.24.47
Total Common Shares Outstanding
6.496.495.52.24.47
Working Capital
2,1162,1931,5491,4911,658
Book Value Per Share
328.28340.61286.41701.18376.34
Tangible Book Value
2,1292,2081,5741,5401,679
Tangible Book Value Per Share
328.12340.44286.15700.14375.30
Machinery
-125.92122.72121.9768.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.